HomeXERS • NASDAQ
add
Xeris Biopharma Holdings Inc
Previous close
$3.04
Day range
$3.02 - $3.10
Year range
$1.69 - $3.63
Market cap
460.66M USD
Avg Volume
1.64M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 54.27M | 12.31% |
Operating expense | 53.57M | 18.96% |
Net income | -15.74M | -29.12% |
Net profit margin | -29.00 | -14.94% |
Earnings per share | -0.06 | 33.33% |
EBITDA | -9.88M | -445.28% |
Effective tax rate | 17.44% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 69.40M | 5.19% |
Total assets | 321.10M | -2.04% |
Total liabilities | 349.43M | 7.87% |
Total equity | -28.32M | — |
Shares outstanding | 149.08M | — |
Price to book | -16.00 | — |
Return on assets | -9.87% | — |
Return on capital | -13.07% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -15.74M | -29.12% |
Cash from operations | -8.30M | 43.16% |
Cash from investing | 9.91M | -32.35% |
Cash from financing | -83.00K | -15.28% |
Net change in cash | 1.53M | 5,751.85% |
Free cash flow | -3.21M | 71.81% |
About
Founded
2005
Headquarters
Website
Employees
377
